Overview

Smoking Cessation Intervention for Thoracic Patients

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Cancer Institute (NCI)
Treatments:
Varenicline